These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21418329)

  • 1. When von Willebrand disease comes into age - a matter of change?
    Miesbach W; Berntorp E
    Eur J Haematol; 2011 Jun; 86(6):496-501. PubMed ID: 21418329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome: an update.
    Franchini M; Lippi G
    Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand Disease.
    Seaman CD; Ragni MV
    Thromb Haemost; 2020 Aug; 120(8):1159-1165. PubMed ID: 32629500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor and aging.
    Konkle BA
    Semin Thromb Hemost; 2014 Sep; 40(6):640-4. PubMed ID: 25151524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of von Willebrand disease.
    Mannucci PM
    Haemophilia; 1998 Jul; 4(4):661-4. PubMed ID: 9873811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.
    Miesbach W; Berntorp E
    Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Emerging Options for the Management of Inherited von Willebrand Disease.
    Heijdra JM; Cnossen MH; Leebeek FWG
    Drugs; 2017 Sep; 77(14):1531-1547. PubMed ID: 28791655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the diagnosis and management of von Willebrand disease.
    Franchini M
    Hematology; 2006 Aug; 11(4):219-25. PubMed ID: 17178659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand Disease: Diagnostic Strategies and Treatment Options.
    Ng CJ; Di Paola J
    Pediatr Clin North Am; 2018 Jun; 65(3):527-541. PubMed ID: 29803281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of inherited von Willebrand disease in 2006.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):616-20. PubMed ID: 16977571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
    Franchini M; Mannucci PM
    Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand disease: pathogenesis and management.
    Rodeghiero F
    Thromb Res; 2013 Jan; 131 Suppl 1():S47-50. PubMed ID: 23452742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis in von Willebrand disease.
    Franchini M; Targher G; Lippi G
    Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.